Corrigendum to "Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-year final clinical outcomes from the MASCOT post-marketing registry" [Int. J. Cardiol. 283 (2019) 67-72]

Colombo A 1 , Chandrasekhar J 2 , Aquino M 2 , Ong TK 3 , Sartori S 2 , Baber U 2 Show all authors , Lee M 4 , Iniguez A 5 , Hajek P 6 , Borisov B 7 , Atzev B 8 , Heijer PD 9 , Coufal Z 10 , Hudec M 11 , Mates M 12 , Snyder C 2 , Moalem K 2 , Morrell D 13 , Elmore F 13 , Rowland S 13 , Mehran R 14 , MASCOT Investigators

Affiliations 

  • 1 San Raffaele Scientific Institute, Milan, Italy
  • 2 Icahn School of Medicine at Mount Sinai, New York, NY, USA
  • 3 Pusat Jantung Hospital Umum Sarawak, Sarawak, Malaysia
  • 4 Queen Elizabeth Hospital, Kowloon, Hong Kong
  • 5 Meixoeiro Hospital - University Hospital of Vigo, Vigo, Spain
  • 6 2nd Faculty of Medicine and Motol University Hospital, Praha, Czech Republic
  • 7 MBAL St. Ivan Rilski, Stara Zagora, Bulgaria
  • 8 MBAL Puls, Blagoevgrad, Blagoevgrad, Bulgaria
  • 9 Amphia Hospital - Breda, Breda, Netherlands
  • 10 T. Bata Regional Hospital Zlin, Zlin, Czech Republic
  • 11 SuSCH Banská Bystrica, Banská Bystrica, Slovakia
  • 12 Nemocnice na Homolce, Praha 5, Czech Republic
  • 13 OrbusNeich Ltd, Fort Lauderdale, FL, USA
  • 14 Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: Roxana.mehran@mountsinai.org
Int J Cardiol, 2019 Oct 01;292:285.
PMID: 31227412 DOI: 10.1016/j.ijcard.2019.04.075

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications